These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23630544)

  • 1. Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.
    Testa JS; Philip R
    Future Virol; 2012 Nov; 7(11):1077-1088. PubMed ID: 23630544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
    Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
    PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
    Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
    Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.
    Testa JS; Shetty V; Sinnathamby G; Nickens Z; Hafner J; Kamal S; Zhang X; Jett M; Philip R
    J Infect Dis; 2012 Feb; 205(4):647-55. PubMed ID: 22246683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
    Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
    Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella.
    Verma NK; Ziegler HK; Stocker BA; Schoolnik GK
    Vaccine; 1995 Feb; 13(3):235-44. PubMed ID: 7543230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.
    De Groot AS; Moise L; Terry F; Gutierrez AH; Hindocha P; Richard G; Hoft DF; Ross TM; Noe AR; Takahashi Y; Kotraiah V; Silk SE; Nielsen CM; Minassian AM; Ashfield R; Ardito M; Draper SJ; Martin WD
    Front Immunol; 2020; 11():442. PubMed ID: 32318055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
    Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
    Hurtgen BJ; Hung CY
    Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytotoxic T-cells in HIV infection.
    Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A
    Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
    Zuckermann FA; Martin S; Husmann RJ; Brandt J
    Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines.
    Bandrick M; Gutiérrez AH; Desai P; Rincon G; Martin WD; Terry FE; De Groot AS; Foss DL
    Vet Immunol Immunopathol; 2020 May; 223():110034. PubMed ID: 32278900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico identification of subunit vaccine candidates against lung cancer-associated oncogenic viruses.
    Lathwal A; Kumar R; Raghava GPS
    Comput Biol Med; 2021 Mar; 130():104215. PubMed ID: 33465550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technologies for MHC class I immunoproteomics.
    Hoppes R; Ekkebus R; Schumacher TN; Ovaa H
    J Proteomics; 2010 Sep; 73(10):1945-53. PubMed ID: 20546957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.